QID 353945

Date Published: 2022-06-09

QID 353945: Amazon Linux Security Advisory for thunderbird : ALAS2-2022-1804

The mozilla foundation security advisory describes this flaw as: an attacker could have sent a message to the parent process where the contents were used to double-index into a javascript object, leading to prototype pollution and ultimately attacker-controlled javascript executing in the privileged parent process. (
( CVE-2022-1529) he mozilla foundation security advisory describes this flaw as: if an attacker was able to corrupt the methods of an array object in javascript via prototype pollution, they could have achieved execution of attacker-controlled javascript code in a privileged context. (
( CVE-2022-1802)



Note: The preceding description block is extracted directly from the security advisory. Using automation, we have attempted to clean and format it as much as possible without introducing additional issues.

Successful exploitation of this vulnerability could lead to a securitybreach or could affect integrity, availability, and confidentiality.

  • CVSS V3 rated as Critical - 8.6 severity.
  • CVSS V2 rated as Medium - 5.4 severity.
    • Solution
    Please refer to Amazon advisory: ALAS2-2022-1804 for affected packages and patching details, or update with your package manager.
    Vendor References

    CVEs related to QID 353945

    CVE-2022-1529 | CVE-2022-1802 |
    Software Advisories
    Advisory ID Software Component Link
    ALAS2-2022-1804 Amazon Linux 2 URL Logo alas.aws.amazon.com/AL2/ALAS-2022-1804.html
    By selecting these links, you may be leaving CVEreport webspace. We have provided these links to other websites because they may have information that would be of interest to you. No inferences should be drawn on account of other sites being referenced, or not, from this page. There may be other websites that are more appropriate for your purpose. CVEreport does not necessarily endorse the views expressed, or concur with the facts presented on these sites. Further, CVEreport does not endorse any commercial products that may be mentioned on these sites. Please address comments about any linked pages to [email protected].